Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06605534 · ClinicalTrials.gov registry record · NA

Leveraging the Emergency Department (LEAD) Study

A NA study of Lung Cancer, sponsored by Hackensack Meridian Health.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
10
Study locations

NCT06605534 is a NA study of Lung Cancer that is actively recruiting participants, run by Hackensack Meridian Health. The registered enrollment target is 100 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (89% lower). The trial reports 10 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06605534, a NA study of Lung Cancer, is actively recruiting participants, sponsored by Hackensack Meridian Health.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
10
Study locations

Study Summary

This is a pilot Type 1 Hybrid Effectiveness-Implementation Trial. The study will first examine reach in a non-traditional setting (the Emergency Department - ED) that uses an Electronic Health Record (EHR)-embedded Social Determinants of Health (SDoH) screening tool to identify lung screening-eligible patients for a tailored intervention to increase lung screening uptake. Reach is defined as the absolute number, proportion, and representativeness of individuals targeted for lung screening knowledge, awareness, and uptake. Then, a pilot trial will be conducted to examine the preliminary effectiveness of a tailored lung screening intervention compared to enhanced usual care to influence individual-level potential drivers of lung screening (health literacy, mistrust, stigma, fatalism, knowledge, lung screening health beliefs) and the ability to increase lung screening uptake among screening-eligible patients. Quantitative (Randomized Controlled Trial and EHR data) methods will be used for data collection and analysis to address the study aims.

Conditions Studied

Lung Cancer

Interventions

  • BEHAVIORAL LungTalk
  • OTHER Non-tailored lung screening

Study Locations (10)

New Jersey

  • Ocean Medical Center - Brick
  • John F. Kennedy Medical Center - Edison
  • Hackensack University Medical Center - Hackensack
  • Bayshore Medical Center - Holmdel
  • Southern Ocean Medical Center - Manahawkin
  • Jersey Shore University Medical Center - Neptune City
  • Palisades Medical Center - North Bergen
  • Old Bridge Medical Center - Old Bridge
  • Raritan Bay Medical Center - Perth Amboy
  • Riverview Medical Center - Red Bank

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-10-29
Est. Completion 2026-10-30
Phase NA

Sponsor

Hackensack Meridian Health

90 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06605534

The ClinicalTrials.gov registry entry for NCT06605534 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (89% lower). The listed sponsor is Hackensack Meridian Health, which has 90 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which LungTalk is the first listed.

NCT06605534 reports 10 study locations spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT06605534 about?

NCT06605534 is a clinical study titled "Leveraging the Emergency Department (LEAD) Study". This is a pilot Type 1 Hybrid Effectiveness-Implementation Trial. The study will first examine reach in a non-traditional setting (the Emergency Department - ED) that uses an Electronic Health Record (EHR)-embedded Social Determinants of Health (SDoH) screening tool to identify lung screening-eligib...

What is the current status of trial NCT06605534?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-10-29. Estimated completion is 2026-10-30.

What conditions does trial NCT06605534 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT06605534?

The interventions under investigation include: LungTalk (BEHAVIORAL), Non-tailored lung screening (OTHER).

Who is sponsoring clinical trial NCT06605534?

This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06605534 being conducted?

This trial has 10 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lung Cancer

All registered trials for this condition

New Jersey

All trials with a study site in New Jersey

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.